Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
COSTS AND EXPENSES:        
Research and development $ 18,133 $ 10,571 $ 33,460 $ 15,247
General and administrative 5,429 3,621 10,838 6,242
  23,562 14,192 44,298 21,489
Operating Loss (23,562) (14,192) (44,298) (21,489)
Interest and other income, net 9 13 92 37
Net loss (23,553) (14,179) (44,206) (21,452)
Warrant deemed dividend 451
Preferred stock deemed dividend 1,260
Net loss available to common stockholders $ (23,553) $ (14,179) $ (44,206) $ (23,163)
Net loss per common share, basic and diluted $ (0.07) $ (0.23) $ (0.14) $ (0.54)
Weighted average common shares outstanding, basic and diluted 331,281,242 62,391,006 310,807,619 43,209,988